Biblioteca Humberto Rosselli Quijano
Información del autor
Autor Andreas Schreiner |
Documentos disponibles escritos por este autor (1)
Refinar búsqueda
Risperidone: An open-label, observational study of the efficacy, tolerability, and prescribing behavior in acutely exacerbated patients with schizophrenia / Frank Gerald Pajonk en Journal of Clinical Psychopharmacology, Año 2005 - Vol. 25 - No. 4 (Agosto)
[artículo]
Título : Risperidone: An open-label, observational study of the efficacy, tolerability, and prescribing behavior in acutely exacerbated patients with schizophrenia Tipo de documento: texto impreso Autores: Frank Gerald Pajonk, Autor ; Andreas Schreiner, Autor ; Stefan Peters, Autor Fecha de publicación: 2023 Artículo en la página: pp. 293-300 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antipsicóticos, Hostilidad, Observación, Patrones de práctica, Risperidona, Esquizofrenia. Resumen: Efficacy of atypical antipsychotic in acute schizophrenic episodes is still in debate. This study evaluated treatment practices over 7 years of initial treatment with oral risperidone in acutely exacerbated patients with schizophrenia and in a subgroup of highly agitated, tense, and aggressive patients. Additionally, the study investigated the efficacy and tolerability of risperidone in routine clinical practice. Link: ./index.php?lvl=notice_display&id=30893
in Journal of Clinical Psychopharmacology > Año 2005 - Vol. 25 - No. 4 (Agosto) . - pp. 293-300[artículo] Risperidone: An open-label, observational study of the efficacy, tolerability, and prescribing behavior in acutely exacerbated patients with schizophrenia [texto impreso] / Frank Gerald Pajonk, Autor ; Andreas Schreiner, Autor ; Stefan Peters, Autor . - 2023 . - pp. 293-300.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2005 - Vol. 25 - No. 4 (Agosto) . - pp. 293-300
Palabras clave: Antipsicóticos, Hostilidad, Observación, Patrones de práctica, Risperidona, Esquizofrenia. Resumen: Efficacy of atypical antipsychotic in acute schizophrenic episodes is still in debate. This study evaluated treatment practices over 7 years of initial treatment with oral risperidone in acutely exacerbated patients with schizophrenia and in a subgroup of highly agitated, tense, and aggressive patients. Additionally, the study investigated the efficacy and tolerability of risperidone in routine clinical practice. Link: ./index.php?lvl=notice_display&id=30893